Inducible nitric oxide synthase is not required for long-term vaccine- based immunity against Toxoplasma gondii

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 2994-3000

  Khan, Imtiaz A ^a   Matsuura, Tadashi ^a   Kasper, Lloyd H ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTOZOAL VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; LYMPHOCYTE DEPLETION; MICROBIAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

ANIMALS; BRAIN CHEMISTRY; ENZYME INDUCTION; GENES, PROTOZOAN; GENETIC MARKERS; IMMUNITY, NATURAL; LIVER; LYMPHOCYTE COUNT; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTOZOAN VACCINES; STEM CELLS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 0032530950     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Kasper, L. H., and J. C. Boothroyd. 1993. Toxoplasma gondii and toxoplasmosis. In Immunology and Molecular Biology of Parasitic Infections. K. Warren, ed. Blackwell Scientific, Boston, p. 269.
2. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286.
3. + T cell clone protects against acute Toxoplasma gondii infection in mice. J. Immunol. 152:1856.
4. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240:516.
5. Suzuki, Y., F. K. Conley, and J. S. Remington. 1989. Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143:2045.
6. McCabe, R. E., B. J. Luft, and J. S. Remington. 1984. Effect of murine interferon γ on murine toxoplasmosis. J. Infect. Dis. 150:961.
7. Nathan, C. F., H. W. Murray, M. E. Wiebe, and B. Y. Rubin. 1983. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:670.
8. Murray, H. W., B. Y. Rubin, S. M. Carriero, A. M. Harris, and E. A. Jaffee. 1985. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent versus oxygen-independent activity against intracellular Toxoplasma gondii. J. Immunol. 134:1982.
9. Mauel, J., A. Ransijn, and Y. Buchmuller-Rouiller. 1991. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives. J. Leukocyte Biol. 49:73.
10. Roach, T. I., A. F. Kiderlen, and J. M. Blackwell. 1991. Role of inorganic nitrogen oxides and tumor necrosis factor a in killing Leishmania donovani amastigotes in γ interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect. Immun. 59:3935.
11. Kreil, T. R., and M. M. Eibl. 1996. Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. Virology 219:304.
12. Chao, C. C., W. R. Anderson, S. Hu., G. Gekker, A. Martella, and P. K. Peterson. 1993. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin. Immunol. Immunopathol. 67:178.
13. Khan, I. A., J. D. Schwartzman, T. Matsuura, and L. H. Kasper. 1997. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc. Natl. Acad. Sci. USA 94:13955.
14. Woods, M. L. D., J. Mayer, T. G. Evans, and J. B. Hibbs, Jr. 1994. Antiparasitic effects of nitric oxide in an in vitro murine model of Chlamydia trachomatis infection and an in vivo murine model of Leishmania major infection. Immunol. Ser. 60:179.
15. Scharton-Kersten, T. M., G. Yap, J. Magram, and A. Sher. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261.
16. Johnson, A. M. 1989. Toxoplasma vaccines. In Protozoan and Hemoparasite vaccines. I. Wright, ed. CRC Press, Boca Raton, FL.
17. + T cells protect against lethal toxoplasmosis in mice infected with Neospora caninum. Infect. Immun. 66:1554.
18. Pfefferkorn, E. R., and L. C. Pfefferekorn. 1976. Toxoplasma gondii: isolation and preliminary characterization of a temperature sensitive mutant. Exp. Parasitol. 39:365.
19. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147:2310.
20. Waldeland, H., E. R. Pfefferkorn, and J. K. Frenkel. 1983. Temperature-sensitive mutants of Toxoplasma gondii: pathogenicity and persistence in mice. J. Parasitol. 69:171.
21. Escajadillo, A., and J. K. Frenkel. 1991. Experimental toxoplasmosis and vaccine tests in Aotus monkeys. Am. J. Trop. Med. Hyg. 44:38.
22. Chardes, T., F. Velge-Roussel, P. Mevelec, M. N. Mevelec, D. Buzoni-Gatel, and D. Bout. 1993. Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice. Immunology 78:421.
23. MacMicking, J. D., C. Nathan, G. Horn, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, N. Hutchinson, et al. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. [Published erratum appears in 1995 Cell 81: 1171.] Cell 81:641.
24. Burg, J. L., C. M. Grover, P. Pouletty, and J. C. Boothroyd. 1989. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol. 27:1787.
25. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1987. Current Protocols in Molecular Biology. Wiley, New York, p. 204.
26. + T cell-mediated immunity against Toxoplasma gondii infection in mice. J. Immunol. 157:2103.
27. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
28. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity 4:471.
29. + T cell immunity against fatal Toxoplasma gondii infection in mice. J. Immunol. 147:3501.
30. + T-cell interactions with Toxoplasma gondii: implications for processing of antigen for class-I-restricted recognition. Res. Immunol. 144:51.
31. + T-cell memory determined by clonal burst size. Nature 369:652.
32. Roach, T. I., C. H. Barton, D. Chatterjee, F. Y. Liew, and J. M. Blackwell. 1995. Opposing effects of interferon-γ on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology 85:106.
33. Igietseme, J. U. 1996. The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide. Immunology 87:1.
34. + cells as effectors of IFN-γ dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J. Exp. Med. 178:1465.
35. 2-microglobulin-deficient mice. J. Immunol. 154:780.
36. + immune T cells against toxoplasmosis in mice. J. Immunol. 144:1954.
37. Scharton-Kersten, T., P. Caspar, A. Sher, and E. Y. Denkers. 1996. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-γ production induced by an attenuated parasite strain. Exp. Parasitol. 84:102.
38. Belich, M. P., R. J. Glynne, G. Senger, D. Sheer, and J. Trowsdale. 1994. Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr. Biol. 4:769.
39. Hunter, C. A., Y. Suzuki, C. S. Subauste, and J. S. Remington. 1996. Cells and cytokines in resistance to Toxoplasma gondii. Curr. Top. Microbiol. Immunol. 219:113.
40. Subauste, C. S., A. H. Koniaris, and J. S. Remington. 1991. Murine CD8 + cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J. Immunol. 147:3955.
41. Kasper, L. H., I. A. Khan, K. H. Ely, R. Buelow, and J. C. Boothroyd. 1992. Antigen-specific (p30) mouse CD8 + T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages. J. Immunol. 148:1493.
42. Utermohlen, O., A. Dangel, A. Tamok, and F. Lehmann-Grube. 1996. Modulation by γ interferon of antiviral cell-mediated immune responses in vivo. J. Virol. 70:1521-.
43. Sharma, D. P., A. J. Ramsay, D. J. Maguire, M. S. Rolph, and I. A. Ramshaw. 1996. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J. Virol. 70:7103.
44. Von Herrath, M. G., B. Coon, and M. B. Oldstone. 1997. Low-affinity cytotoxic T-lymphocytes require IFN-γ to clear an acute viral infection. Virol. 229:349.
45. Denkers, E. Y., G. Yap, T. Scharton-Kersten, H. Charest, B. A. Butcher, P. Caspar, S. Heiny, and A. Sher. 1997. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J. Immunol. 159:1903.
46. Clark, W. R., C. M. Walsh, A. A. Glass, M. T. Huang, R. Ahmed, and M. Matloubian. 1995. Cell-mediated cytotoxicity in perform-less mice. Int. Rev. Immunol. 13:1.
47. + T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur. J. Immunol. 24:3068.
48. Greenberg, M. L., S. F. Lacey, C. H. Chen, D. P. Bolognesi, and K. J. Weinhold. 1997. Noncytolytic CD8 T cell-mediated suppression of HIV replication. Springer Semin. Immunopathol. 18:355.